Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:25 PM
Ignite Modification Date:
2025-12-24 @ 11:25 PM
NCT ID:
NCT02176356
Eligibility Criteria:
Inclusion Criteria:
* Qualified to receive treatment with BOTOX® Cosmetic, a facial filler (JUVÉDERM® ULTRA XC and/or JUVÉDERM® ULTRA Plus XC and/or JUVÉDERM® VOLUMA® XC) and LATISSE® treatment
* Naïve to botulinum toxin therapy of any serotype for any indication
* Naïve to prescription eyelash growth products of any type
* Naïve to dermal filler treatment in the face and neck
Exclusion Criteria:
* Undergone facial plastic surgery, tissue grafting, tissue augmentation or facial dermal filler injections
* Had laser, photomodulation, intense pulsed light, radio frequency, dermabrasion or chemical peel in the face or neck
* Have received skin resurfacing (laser, photomodulation, intense pulsed light, radio frequency, dermabrasion, chemical peel, or non-ablative procedures) in the face or neck within 3 months
* Systemic retinoid therapy within 1 year prior to study enrollment
* Presence of inflammation at the proposed injection site(s)
* Profound atrophy/excessive weakness of muscles in target areas of injection
* Known immunization or hypersensitivity to any botulinum toxin serotype
* Undergone oral surgery or dental procedures within 30 days
* No visible eyelashes
* Use of permanent eyeliner, eyelash implants, semi-permanent eyelash tint, dye or extension
* Use of prescription eyelash growth products
* Unwilling or unable to remove contact lenses prior to study medication application in the evening and keep lenses out for 30 minutes
* Diagnosis of myasthenia gravis, Eaton-Lambert Syndrome, amyotrophic lateral sclerosis, or any other disease that might interfere with neuromuscular function.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
35 Years
Maximum Age:
65 Years
Study:
NCT02176356
Study Brief:
Protocol Section:
NCT02176356